Snowden Capital Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Snowden Capital Advisors's ABMD Position: Q4 2022 in Review
Snowden Capital Advisors sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,725 shares — an estimated $423K sold.
Snowden Capital Advisors first reported a position in ABMD in Q2 2016 and held it in 25 quarters. The position peaked at $10.3M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Snowden Capital Advisors reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Snowden Capital Advisors sold 1,725 Abiomed Inc shares in Q4 2022, an estimated $423K.
- Snowden Capital Advisors first reported a position in Abiomed Inc in Q2 2016 and held it in 25 quarters.
- Snowden Capital Advisors's Abiomed Inc position peaked at $10.3M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Snowden Capital Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.